Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03131999 · ClinicalTrials.gov registry record · Phase 1
LAM Pilot Study With Imatinib Mesylate
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT03131999 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 18 participants.
The verdict
NCT03131999, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a phase 1 clinical trial comparing imatinib mesylate to placebo for individuals with lymphangioleiomyomatosis (LAM).
Interventions
- DRUG Imatinib Mesylate 400Mg Capsule
- DRUG Placebo - Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-01-23 |
| Est. Completion | 2019-03-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03131999
The ClinicalTrials.gov registry entry for NCT03131999 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Imatinib Mesylate 400Mg Capsule is the first listed.
NCT03131999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03131999 about?
NCT03131999 is a clinical study titled "LAM Pilot Study With Imatinib Mesylate". This is a phase 1 clinical trial comparing imatinib mesylate to placebo for individuals with lymphangioleiomyomatosis (LAM).
What is the current status of trial NCT03131999?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2018-01-23. Estimated completion is 2019-03-07.
What interventions are being tested in trial NCT03131999?
The interventions under investigation include: Imatinib Mesylate 400Mg Capsule (DRUG), Placebo - Capsule (DRUG).
Who is sponsoring clinical trial NCT03131999?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.